Clinical TrialsBempikibart Maintains Responses After Treatment Discontinuation in Alopecia... Bempikibart Maintains Responses After Treatment Discontinuation in Alopecia... Read Post »
Health TidingsHighlight Therapeutics Reports Positive BO-112 Phase 2b Results in BCC Highlight Therapeutics Reports Positive BO-112 Phase 2b Results in BCC Read Post »
Clinical TrialsTulisokibart Meets Phase 2b Endpoint in Hidradenitis Suppurativa Tulisokibart Meets Phase 2b Endpoint in Hidradenitis Suppurativa Read Post »
Clinical TrialsRademikibart Reduces Treatment Failure by 81% in Phase 2 COPD Exacerbation ... Rademikibart Reduces Treatment Failure by 81% in Phase 2 COPD Exacerbation ... Read Post »
